CIK 0001119774 · Accelerated filer
COMPUGEN LTD
Sign in to watch- Ticker
- CGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- other
- Phone
- 011-972-3-765-8585
- Business address
- 26 HAROKMIM STREET, BUILDING D, HOLON, Israel, 5885849
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-01 | Ophir Eran President and CEO | Sale 10b5-1 | −5,625 | $2.21 | $12K | 11,375 |
| 2026-04-01 | Ophir Eran President and CEO | Option exercise · Share Option (right to buy) 10b5-1 | −5,625 | 24,375 | ||
| 2026-03-26 | Levine Zurit SVP, Business Development | Option exercise 10b5-1 | +11,875 | $0.83 | $10K | 41,250 |
| 2026-03-26 | Levine Zurit SVP, Business Development | Sale 10b5-1 | −11,875 | $2.04 | $24K | 29,375 |
| 2026-03-26 | Levine Zurit SVP, Business Development | Option exercise · Share Option (right to buy) 10b5-1 | −11,875 | 16,125 |
Page 4 of 4 · 65 trades